Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO

Prof. Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO

Head, Corneal Research Group, The University of Sydney, Save Sight Institute, Faculty of Medicine and Health; co-Deputy Director, Industry, Innovation and Commercialisation, Sydney Nano; Head, Corneal Unit, Sydney Eye Hospital; Chair, Australian Vision Research, Sydney, New South Wales, Australia

Professor Stephanie Watson OAM is a corneal surgeon known for her ground-breaking research in corneal therapies. She leads the Corneal Research Group at University of Sydney and is Head of the Corneal Unit at the Sydney Eye Hospital. For Sydney Nano she contributes to the executive leadership team as co-Deputy Director for Industry, Innovation and Commercialisation. As Chair, Australian Vision Research; recent past-Chair to the Association for Research in Vision and Ophthalmology's (ARVO) Advocacy and Outreach Committee Professor Watson has contributed to policy and advocacy. Her practice is in corneal and cataract surgery in adults and children with appointments at the Sydney Eye Hospital, Sydney Children's and Prince of Wales Hospitals where she is a RANZCO trainer. The Medal of the Order of Australia was awarded for services to ophthalmology. Professor Watson was the only Australian to make the Power List of the Top 100 women in Ophthalmology in 2021 and in 2022 and 2023 the only Australian woman on the Top 100 Global Power list for all ophthalmologists. In 2023, Professor Watson was awarded the Asia Pacific Eye 100: 100 Most influential Ophthalmologists and the Asia Pacific Academy of Ophthalmology Outstanding Service in Prevention of Blindness Award. She has received ARVO Silver Fellowship, New Zealand's Dorothy Potter Medal and an NSW Premier's Prize for Leadership in Innovation.

Disclosures

Dr. Watson has advised Novartis, Glakos and Sequirus, Alcon and Okogen

Recent Contributions to PracticeUpdate:

  1. Effects of Eyelash Extensions on the Ocular Surface
  2. Efficacy of Meibomian Gland Expression Combined With Home-Based Therapy in the Management of Dry Eye Disease
  3. 2023 Top Story in Eye Care: Diagnosing Dry Eye Disease — Which Tests Are Most Accurate?
  4. Ocular Symptoms in Adolescents and Young Adults Using E-Cigarettes, Cigarettes, or Both
  5. Efficacy and Safety of 1% and 2% Rebamipide Clear Solution in Patients With Dry Eye Disease
  6. Symptoms of Dry Eye Disease Related to the Relative Humidity of Living Places
  7. Effectiveness of Autologous Serum Eye Drops for the Treatment of Dry Eye Disease
  8. Ocular Surface Disease as an Extraesophageal Gastroesophageal Reflux Disease Manifestation
  9. Detection Ability of Corneal Biomechanical Parameters for Early Diagnosis of Ectasia
  10. Incidence, Clinical Features, and Outcomes of Multidrug-Resistant Keratitis

Most Read This Week

Recently Updated